uMed Health Tech Expands Clinical Research Platform
London-based healthtech startup secures £3.7m funding for its clinical research platform.
17:54 03 December 2020
uMed, a London-based research technology company, has recently secured £32.million in funding from venture capital investors, including Playfair Capital, Delin Ventures and AlbionVC.
The funding will be used in the development of tools that will help healthcare providers in the UK and US run patient research more efficiently while safeguarding data and ensuring regulatory compliance.
Dr Matt Wilson, uMed's founder and CEO said: “Our technology can support healthcare providers in finding appropriate patients to participate in medical research including large scale patient registries which usually demands laborious, manual processes on top of their already complex and heavy workloads.
“As our technology is uniquely able to reach back compliantly from the Electronic Health Record (EHR) to the patients, the process for building research registries can be heavily automated. It means clinicians can focus on patient care, while patients are allowed to participate in many more studies from home with full transparency over use of their health records.”
Christoph Ruedig, Partner at AlbionVC, comments: “AlbionVC has been investing in digital health for more than 10 years. We believe the next generation of healthcare disruptors are companies that can harness the power of that data to help improve healthcare. uMed has developed a powerful platform that can link some of the richest sources of healthcare data and drive a step change in how clinical and real-world research is conducted. We have been impressed by the company and its vision, and we are excited to support them as they enter the next stage of growth.”